Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need

By LabMedica International staff writers
Posted on 07 Sep 2022

When the requirement is for infectious disease testing, every minute counts to inform treatment decisions and slow the risk of transmission. More...

Having rapid multiplex PCR testing at the point of need can make life better for millions of people in hospitals, clinics, airports, care homes, events, workplaces, and a wider variety of other settings. Now, a portable and simple to use rapid multiplex PCR testing system delivers fast, accurate and actionable results in approximately 30 minutes at the point of need.

The Q-POC platform from QuantuMDx Group Ltd. (Tyne and Wear, UK) compresses an entire molecular diagnosis laboratory into a simple-to-use, accessible and portable single device that produces results in approximately 30 minutes. The many innovative features incorporated into the Q-POC platform make it a safe rapid multiplex PCR testing solution for all clinical environments. With the Q-POC supercharged platform, it is no longer necessary to wait hours or days for test results.

The Q-POCT platform has been engineered to limit the need for highly skilled operators and offer a smooth user experience behind each interaction with its intuitive interface. The software is designed with the simplicity and familiarity of smartphone and tablet interfaces. It requires only three minutes hands-on-time to get each test started, using easy to follow, guided workflows on the touch screen. A ready to use solution, with all its simplicity, accuracy and speed, the Q-POCT requires no calibration or preventive maintenance. Each test cassette contains all the necessary reagents to complete a test and can be stored and shipped at room temperature. Users can just load the cassette and press go.

A ton of tech is behind every result, with intelligent multilingual software algorithms integrated into the Q-POCT platform. Clear, simple test results are automatically generated by sophisticated software algorithms, removing any complicated interpretation of the result. The Q-POCT software has been designed with the user in mind and uses intuitive, user centric software design similar to a smartphone allowing clear and easy reporting. The small, portable, battery-operated Q-POCT system marks a huge leap in rapid multiplex PCR testing. Its compact design, as well as its internal lithium-ion battery, supports use in a wide variety of clinical settings, at the Point of Need.

Related Links:
QuantuMDx Group Ltd. 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.